Status:
RECRUITING
Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Unilateral Deafness
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
Single-sided deafness (SSD) refers to severe to profound sensorineural hearing loss on one side (average pure-tone hearing threshold≥70 dB HL at 0.5, 1, 2, and 4kHz) while the opposite side maintains ...
Detailed Description
Current options for hearing interventions for patients with SSD are air conduction hearing aids, bone conduction hearing aids and cochlear implants. Attributed to the United States Food and Drug Admin...
Eligibility Criteria
Inclusion
- Age: 12 years old and above
- Language ability: postlingual deafness, able to cooperate with sentence test in noise
- Normal mental, intelligence and motor development
- Patients who meet the diagnosis of single-sided deafness and asymmetric hearing loss
Exclusion
- Cochlear malformation (except large vestibular aqueduct syndrome)
- Retrocochlear lesions
- Incomplete implantation of cochlear implant electrodes
- Non-Chinese Mandarin communication
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05435612
Start Date
July 5 2022
End Date
July 1 2026
Last Update
June 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100085